Status:
COMPLETED
Inhibitory Receptors in Eosinophils of Atopic Subjects
Lead Sponsor:
Meir Medical Center
Conditions:
Atopy
Atopic Dermatitis
Eligibility:
All Genders
20-60 years
Brief Summary
The purpose of this study is to analyze the expression and activity of inhibitory molecules on eosinophils obtained from allergic subjects.
Eligibility Criteria
Inclusion
- age 20-60 years
- a physician-diagnosed atopic disease
Exclusion
- atopic disease not active
- steroid treatment
- active non-atopic inflammatory disease, including infections
- pregnancy
Key Trial Info
Start Date :
May 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2013
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01489293
Start Date
May 1 2012
End Date
December 31 2013
Last Update
March 22 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Meir Medical Center. Unit of Allergy and Clinical Immunology
Kfar Saba, Israel